Most Favored Patient Act of 2026
Summary
The Most Favored Patient Act of 2026 aims to lower drug prices by requiring the Center for Medicare and Medicaid Innovation (CMMI) to test a model that implements most-favored-nation drug pricing. This model would require drug manufacturers to offer the lowest price available in certain reference countries to eligible individuals in the US. The Act amends Title XI of the Social Security Act to mandate this pricing model, starting January 1, 2029, for a period of 5 years.
Expected Effects
If enacted, the Most Favored Patient Act of 2026 could lead to lower drug costs for Medicare and Medicaid beneficiaries. It could also incentivize drug manufacturers to lower prices in the United States to match international rates. However, it might also lead to manufacturers increasing prices in other countries or reducing the availability of certain drugs in the US.
Potential Benefits
- Potentially lower drug prices for Medicare and Medicaid beneficiaries.
- Could incentivize drug manufacturers to lower prices in the US.
- May lead to increased price transparency in the pharmaceutical market.
- Could reduce overall healthcare spending.
- May encourage domestic manufacturing through covered agreements.
Potential Disadvantages
- Potential for drug manufacturers to increase prices in other countries.
- Possible reduction in the availability of certain drugs in the US.
- May discourage pharmaceutical innovation if profitability is reduced.
- Risk of manufacturers avoiding the requirements through covered agreements.
- Administrative complexity in calculating and implementing the most-favored-nation price.
Most Disadvantaged Areas:
Constitutional Alignment
The Act appears to align with the general welfare clause of the Constitution, as it aims to improve healthcare affordability. Congress has the power to regulate interstate commerce, which includes the pharmaceutical industry. The Act's implementation through the CMMI falls under Congress's authority to legislate on matters related to Social Security and healthcare.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).